SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.09 Cr | ₹9.84 Cr | ₹-0.48 Cr | ₹-0.18 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.09 Cr |
| Mar2024 | ₹9.84 Cr |
| Mar2020 | ₹-0.48 Cr |
| Mar2019 | ₹-0.18 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.09 Cr | Negative | |
| Mar2024 | ₹9.84 Cr | Positive | |
| Mar2020 | ₹-0.48 Cr | Negative | |
| Mar2019 | ₹-0.18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹796.5 Cr | 12.2% | 20.7% | -22.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 12.2% |
20.7% |
-22.9% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses